SCHEDULE 13G: BlackRock Discloses 5.1% Stake in KORU Medical Systems

BlackRock, Inc. has reported a 5.1% beneficial ownership stake in KORU Medical Systems Inc., holding 2,345,369 shares of common stock.

Summary

• BlackRock, Inc. has disclosed a beneficial ownership of 2,345,369 shares of KORU Medical Systems Inc. common stock as of December 31, 2025.
• This ownership represents 5.1% of the total outstanding common stock of KORU Medical Systems Inc.
• BlackRock, Inc. holds sole voting power over 2,308,684 shares and sole dispositive power over 2,345,369 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of KORU Medical Systems Inc.
• Several BlackRock subsidiaries, including BlackRock Advisors, LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, National Association, BlackRock Financial Management, Inc., and BlackRock Investment Management, LLC, beneficially own 5% or greater of the outstanding shares.

Sentiment

Score: 7

Explanation: The filing indicates a significant institutional investment by BlackRock, a leading asset manager, suggesting confidence in KORU Medical Systems Inc. This is generally viewed as a positive signal, even if it's a passive stake.

Positives

• A significant institutional investment by BlackRock, a major asset manager, indicates a degree of confidence in KORU Medical Systems Inc.'s prospects.
• The passive nature of the stake, held in the ordinary course of business, suggests a long-term investment perspective rather than an activist intent.

Risks

• No specific risks related to KORU Medical Systems Inc. are detailed in this beneficial ownership report.

Future Outlook

No forward-looking statements or guidance regarding KORU Medical Systems Inc.'s performance or future operations are provided in this beneficial ownership filing.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

BlackRock's disclosure of a 5.1% stake in KORU Medical Systems Inc. indicates continued institutional interest in the healthcare and medical device sector. Such a significant holding by a major asset manager can be viewed as a positive signal within the industry, potentially drawing further attention to KORU Medical Systems Inc. from other institutional investors.

Stakeholder Impact

• Shareholders of KORU Medical Systems Inc. may perceive BlackRock's significant stake as a vote of confidence from a major institutional investor, potentially bolstering investor sentiment.
• The presence of a large, passive institutional holder like BlackRock can contribute to market stability for the company's stock.

Key Dates

Recommendation

BlackRock's disclosure of a 5.1% passive stake in KORU Medical Systems Inc. indicates institutional confidence. While not an active investment seeking control, it suggests a positive long-term view from a major asset manager. This information alone is insufficient for a 'buy' or 'sell' recommendation, but it supports a 'hold' given the implied institutional backing and potential for increased market visibility.

Keywords

KORU Medical Systems, BlackRock, institutional ownership, beneficial ownership, common stock, Schedule 13G, healthcare, medical devices